488 related articles for article (PubMed ID: 27195769)
1. Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin.
Yokoyama C; Aoyama T; Ido T; Kakino A; Shiraki T; Tanaka T; Nishigaki K; Hasegawa A; Fujita Y; Sawamura T; Minatoguchi S
PLoS One; 2016; 11(5):e0154994. PubMed ID: 27195769
[TBL] [Abstract][Full Text] [Related]
2. LOX-1 plays an important role in ischemia-induced angiogenesis of limbs.
Shiraki T; Aoyama T; Yokoyama C; Hayakawa Y; Tanaka T; Nishigaki K; Sawamura T; Minatoguchi S
PLoS One; 2014; 9(12):e114542. PubMed ID: 25514797
[TBL] [Abstract][Full Text] [Related]
3. Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice.
Nozaki N; Shishido T; Takeishi Y; Kubota I
Circulation; 2004 Nov; 110(18):2869-74. PubMed ID: 15505089
[TBL] [Abstract][Full Text] [Related]
4. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
[TBL] [Abstract][Full Text] [Related]
5. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) and cardiac fibroblast growth.
Wang X; Khaidakov M; Ding Z; Mitra S; Lu J; Dai Y; Mehta JL
Hypertension; 2012 Dec; 60(6):1437-42. PubMed ID: 23045471
[TBL] [Abstract][Full Text] [Related]
6. DUSP14 knockout accelerates cardiac ischemia reperfusion (IR) injury through activating NF-κB and MAPKs signaling pathways modulated by ROS generation.
Lin B; Xu J; Feng DG; Wang F; Wang JX; Zhao H
Biochem Biophys Res Commun; 2018 Jun; 501(1):24-32. PubMed ID: 29660332
[TBL] [Abstract][Full Text] [Related]
7. Galectin-3 aggravates ox-LDL-induced endothelial dysfunction through LOX-1 mediated signaling pathway.
Ou HC; Chou WC; Hung CH; Chu PM; Hsieh PL; Chan SH; Tsai KL
Environ Toxicol; 2019 Jul; 34(7):825-835. PubMed ID: 30963716
[TBL] [Abstract][Full Text] [Related]
8. Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice.
Shizukuda Y; Matoba S; Mian OY; Nguyen T; Hwang PM
Mol Cell Biochem; 2005 May; 273(1-2):25-32. PubMed ID: 16013437
[TBL] [Abstract][Full Text] [Related]
9. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet.
Mehta JL; Sanada N; Hu CP; Chen J; Dandapat A; Sugawara F; Satoh H; Inoue K; Kawase Y; Jishage K; Suzuki H; Takeya M; Schnackenberg L; Beger R; Hermonat PL; Thomas M; Sawamura T
Circ Res; 2007 Jun; 100(11):1634-42. PubMed ID: 17478727
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy.
Sun A; Cheng Y; Zhang Y; Zhang Q; Wang S; Tian S; Zou Y; Hu K; Ren J; Ge J
J Mol Cell Cardiol; 2014 Jun; 71():92-104. PubMed ID: 24434637
[TBL] [Abstract][Full Text] [Related]
11. Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells.
Hossain E; Ota A; Karnan S; Damdindorj L; Takahashi M; Konishi Y; Konishi H; Hosokawa Y
Toxicol Appl Pharmacol; 2013 Dec; 273(3):651-8. PubMed ID: 24145059
[TBL] [Abstract][Full Text] [Related]
12. CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes.
Mukhopadhyay P; Rajesh M; Bátkai S; Patel V; Kashiwaya Y; Liaudet L; Evgenov OV; Mackie K; Haskó G; Pacher P
Cardiovasc Res; 2010 Mar; 85(4):773-84. PubMed ID: 19942623
[TBL] [Abstract][Full Text] [Related]
13. Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice.
Thandavarayan RA; Watanabe K; Sari FR; Ma M; Lakshmanan AP; Giridharan VV; Gurusamy N; Nishida H; Konishi T; Zhang S; Muslin AJ; Kodama M; Aizawa Y
Free Radic Biol Med; 2010 Nov; 49(9):1422-31. PubMed ID: 20705132
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk between LOX-1 and PCSK9 in vascular tissues.
Ding Z; Liu S; Wang X; Deng X; Fan Y; Shahanawaz J; Shmookler Reis RJ; Varughese KI; Sawamura T; Mehta JL
Cardiovasc Res; 2015 Sep; 107(4):556-67. PubMed ID: 26092101
[TBL] [Abstract][Full Text] [Related]
15. LOX-1 deletion alters signals of myocardial remodeling immediately after ischemia-reperfusion.
Hu C; Dandapat A; Chen J; Fujita Y; Inoue N; Kawase Y; Jishage K; Suzuki H; Sawamura T; Mehta JL
Cardiovasc Res; 2007 Nov; 76(2):292-302. PubMed ID: 17707356
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA.
Wang X; Khaidakov M; Ding Z; Mitra S; Lu J; Liu S; Mehta JL
Exp Biol Med (Maywood); 2012 Dec; 237(12):1394-401. PubMed ID: 23354398
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-κB pathway.
Zhao W; Ma G; Chen X
Vascul Pharmacol; 2014 Dec; 63(3):162-72. PubMed ID: 25135647
[TBL] [Abstract][Full Text] [Related]
18. Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signaling.
Thandavarayan RA; Giridharan VV; Arumugam S; Suzuki K; Ko KM; Krishnamurthy P; Watanabe K; Konishi T
PLoS One; 2015; 10(3):e0119214. PubMed ID: 25742619
[TBL] [Abstract][Full Text] [Related]
19. Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells.
Guo RM; Xu WM; Lin JC; Mo LQ; Hua XX; Chen PX; Wu K; Zheng DD; Feng JQ
Mol Med Rep; 2013 Aug; 8(2):603-8. PubMed ID: 23807148
[TBL] [Abstract][Full Text] [Related]
20. Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C.
Ludke A; Akolkar G; Ayyappan P; Sharma AK; Singal PK
PLoS One; 2017; 12(7):e0179452. PubMed ID: 28678856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]